Page 5 of 12

PS9.2 | LGBTQA+ Inclusive Psychiatric Practice — SDL Guide (Part 2)

Method — Inclusive Clinical Practice Techniques

Affirmative psychiatric practice is not a separate clinical method — it is mainstream clinical method applied with awareness of minority stress, legal rights, and the specific vulnerabilities of LGBTQA+ patients. The following techniques are evidence-based, ethically required, and practical in any outpatient setting.

Language and pronouns: begin every new consultation by asking how the patient would like to be addressed and which pronouns they use. 'What name and pronouns would you like me to use?' is a brief, respectful question that signals safety and respect. Correcting staff who misgender a patient (in a non-shaming way) is the clinician's professional responsibility within their facility. Using chosen names for transgender young people is associated with a significant reduction in suicidality in research literature.

Clinical environment: display visible signals of inclusivity (e.g., inclusive signage, a non-binary toilet option, intake forms with inclusive gender fields). In psychiatric consultations, these signals communicate — before a word is spoken — that the space is safe.

History-taking: when taking a psychiatric or sexual history, do not assume gender, relationship structure, or sexual orientation. Use gender-neutral language for partners ('Do you have a partner?', not 'Is your husband/wife supportive?'). Ask about sexual orientation and gender identity in the same matter-of-fact tone as you ask about marital status — normalisation signals that the information will be handled respectfully. Ask about minority-specific stressors explicitly: Has the patient disclosed their identity to family, colleagues? Have they experienced discrimination, violence, or family rejection? These are clinical risk factors, not prying.

Confidentiality and disclosure: the duty of confidentiality is absolute unless the patient consents to disclosure or there is a statutory duty (imminent risk of harm). LGBTQA+ patients may not want family members — who may be hostile to their identity — informed of their identity or diagnoses. Clarify early who the patient consents to information being shared with.

Assessment of comorbidities with LGBTQA+-specific prevalence: in the clinical assessment, actively screen for depression and anxiety (elevated prevalence), substance use (often used as a coping mechanism for minority stress), self-harm, and suicidality (elevated in transgender youth and in gay/bisexual men). Screen for trauma history, including identity-based violence and family rejection. For transgender patients, assess whether they are accessing gender-affirming care and any associated medical needs.

Formulation: in the psychiatric formulation of an LGBTQA+ patient, include minority stress as a contributing aetiological factor where relevant. 'Patient presents with major depressive disorder, in the context of family rejection following recent coming-out disclosure and workplace discrimination' is a more complete and more accurate formulation than 'patient has depression.' The biopsychosocial model explicitly accommodates social stressors — use it.

Interpretation of Findings — Distinguishing Minority Stress from Psychopathology

One of the most clinically consequential skills in this domain is the ability to distinguish minority-stress-related distress from a diagnosable mental disorder requiring pharmacological treatment. Over-medicalisation of normal responses to unjust social conditions is itself a form of iatrogenic harm.

Consider a 22-year-old gay man who presents with low mood, sleep disturbance, and loss of interest in activities following rejection by his family after coming out. He has no prior psychiatric history, no anhedonia to activities outside the home context, and no suicidal ideation. He is experiencing grief, anger, and social isolation. This presentation does not automatically constitute major depressive disorder — it is an understandable human response to a significant social loss. The clinical task is to assess: Is the distress time-limited and proportionate? Are there other supports? Is there evidence of clinical-level impairment in function across domains?

Conversely, do not minimise genuine psychiatric illness as 'just a social problem.' If the same patient presents six months later with persistent anhedonia, psychomotor retardation, hopelessness, and passive suicidal ideation, a diagnosis of major depressive episode is appropriate and requires treatment — in addition to social support. The key clinical principle is that the source of distress does not determine whether it constitutes a clinical disorder; severity, duration, functional impairment, and criterion-threshold do.

For transgender patients seeking gender-affirming care, psychiatric assessment (where requested by the care team) is an opportunity to screen for comorbid mental health conditions, assess coping resources, and provide support — NOT to gatekeep gender-affirming treatment by requiring proof of 'stability.' Current international guidelines (WPATH Standards of Care 8) do not require a psychiatric 'clearance' as a precondition for hormonal therapy in adults. The psychiatric role is supportive and collaborative, not adjudicatory.

Distinguish the following:
- Minority stress and social grief: distress proportionate to social stressors; time-limited without other indicators of disorder; requires social support, psychoeducation, and possibly brief psychotherapy.
- Internalised homophobia/transphobia: the patient has absorbed societal stigma and experiences shame, self-loathing, or a wish to change their orientation/identity as a result of that internalised prejudice — not a disorder, but a clinical target for supportive and affirmative therapy.
- Diagnosable mental disorder in an LGBTQA+ patient: depression, anxiety, PTSD, substance use disorders meeting diagnostic criteria — require standard evidence-based treatment, with minority stress acknowledged in the formulation.
- Gender incongruence (ICD-11 HA60–HA61): a significant incongruence between experienced/expressed gender and assigned sex at birth; classified in Chapter 17 (not mental disorders); requires access to gender-affirming care, not psychiatric treatment of the incongruence itself.

Applied Practice — Case-Based Clinical Scenarios

The principles covered in this module become most meaningful when applied to concrete clinical encounters. The following scenarios illustrate how to integrate legal knowledge, affirmative clinical method, and sound psychiatric formulation.

Scenario A: The disclosure in an inpatient unit
A 28-year-old man is admitted to a psychiatric ward following a suicide attempt. During the admission interview, he discloses that he is gay and that his suicide attempt followed his parents discovering his relationship and threatening to disown him. He asks you not to tell anyone — including his parents, who are present and asking for information.

The correct response: Respect his confidentiality absolutely regarding his sexual orientation. Under the MHCA 2017, he has the right to nominate who receives information and the right to privacy. His family does not have an automatic right to know his sexual orientation. You may inform the family that he is receiving treatment and is medically stable — without disclosing the precipitating cause. If safety risk arises (active suicidal plan with means), the threshold for disclosure shifts — but the disclosure is about safety, not about 'exposing' his orientation. Document his chosen name, pronouns, and confidentiality preferences clearly in the notes.

Scenario B: A request for conversion therapy
A family brings their 20-year-old son requesting 'treatment' to change his homosexual orientation. They believe this is appropriate psychiatric care. The young man is distressed but has not expressed a personal wish for change — he is distressed about his family's reaction.

The correct response: Explain clearly and compassionately to the family that homosexuality is not a mental disorder (ICD-11, Navtej Johar 2018), that conversion therapy has no scientific evidence of efficacy, and that it causes documented psychological harm. It is unethical and constitutes professional misconduct under NMC guidelines. You are obligated to decline. Offer to work with the young man on managing his distress and with the family on accepting their son — family systemic therapy is an evidence-based alternative. If the young man is being coerced, this raises safeguarding concerns.

Scenario C: Formulating and treating minority-stress depression
A 34-year-old lesbian woman presents with low mood, poor sleep, reduced concentration, and hopelessness for three months following a break-up from a long-term partner and an episode of workplace harassment. She meets DSM-5/ICD-11 criteria for a major depressive episode.

The correct response: Diagnose and treat the depressive episode — SSRIs are first-line pharmacotherapy. The formulation should explicitly include minority stress as a predisposing and precipitating factor: 'This episode occurs in the context of recent relationship loss compounded by identity-based workplace hostility, in a person with prior exposure to chronic minority stress.' Address the social stressor through psychotherapy (CBT, interpersonal therapy), and ensure she knows about LGBTQA+-affirming support networks. Treating the depression without contextualising the social environment is insufficient.